Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. Read more about Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Read more about Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
When progressive disease does not mean treatment failure: reconsidering the criteria for progression. Read more about When progressive disease does not mean treatment failure: reconsidering the criteria for progression.
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. Read more about Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial. Read more about Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. Read more about Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.
Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review. Read more about Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
CYP3A variation, premenopausal estrone levels, and breast cancer risk. Read more about CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Bupropion for smoking cessation in African American light smokers: a randomized controlled trial. Read more about Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
